Zobrazeno 1 - 10
of 163
pro vyhledávání: '"Gr Siber"'
Autor:
[No Value] Groothuis, Gr Siber, Wj Rodriguez, Vg Hemming, Ga Prince, Julita O. Arrobio, Mj Levin, Fulton, Ce Long, Rc Welliver, Hc Meissner, M Vanraden, Cb Hall, Da Tristram, Eaf Simoes
Publikováno v:
New England Journal of Medicine. 329:1524-1530
Background Infants with cardiac disease or prematurity are at risk for severe illness caused by respiratory syncytial virus. Immune globulin with a high titer of antibodies against respiratory syncytial virus may offer infants and young children at r
Autor:
Sp, Schwendeman, Hr, Costantino, Rk, Gupta, Tobio M, Ac, Chang, Maria Jose Alonso, Gr, Siber, Langer R
Publikováno v:
Europe PubMed Central
The stability of tetanus toxoid (TT) has been investigated for the purpose of enhancing its immunogenicity when encapsulated in TT-polylactide-co-glycolide (PLGA) microspheres. In this paper we describe our simulations of various potential inactivati
Autor:
Earle KA; Vaccine Development & Surveillance, Bill & Melinda Gates Foundation, 500 5th Ave N, Seattle, WA 98109, USA., Ambrosino DM; Independent Advisor, Stuart, FL, USA., Fiore-Gartland A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA 98109, USA., Goldblatt D; Great Ormond Street Institute of Child Health, University College London, 30 Guilford Street, London WC1N 1EH, UK., Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA 98109, USA., Siber GR; Independent Advisor, New York, NY, USA., Dull P; Vaccine Development & Surveillance, Bill & Melinda Gates Foundation, 500 5th Ave N, Seattle, WA 98109, USA. Electronic address: Peter.Dull@gatesfoundation.org., Plotkin SA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, 3401 Civic Center Blvd., Philadelphia, PA 19104, USA.
Publikováno v:
Vaccine [Vaccine] 2021 Jul 22; Vol. 39 (32), pp. 4423-4428. Date of Electronic Publication: 2021 May 24.
Autor:
Lipsitch M; Center for Communicable Disease Dynamics, Department of Epidemiology and Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA mlipsitc@hsph.harvard.edu., Siber GR; ClearPath Vaccines, Rockville, Maryland, USA.
Publikováno v:
MBio [mBio] 2016 Jun 07; Vol. 7 (3). Date of Electronic Publication: 2016 Jun 07.
Resolution of Chlamydia trachomatis Infection Is Associated with a Distinct T Cell Response Profile.
Autor:
Picard MD; Genocea Biosciences, Inc., Cambridge, Massachusetts, USA michele.picard@genocea.com., Bodmer JL; Genocea Biosciences, Inc., Cambridge, Massachusetts, USA., Gierahn TM; Genocea Biosciences, Inc., Cambridge, Massachusetts, USA., Lee A; Genocea Biosciences, Inc., Cambridge, Massachusetts, USA., Price J; Genocea Biosciences, Inc., Cambridge, Massachusetts, USA., Cohane K; Genocea Biosciences, Inc., Cambridge, Massachusetts, USA., Clemens V; Genocea Biosciences, Inc., Cambridge, Massachusetts, USA., DeVault VL; Genocea Biosciences, Inc., Cambridge, Massachusetts, USA., Gurok G; Genocea Biosciences, Inc., Cambridge, Massachusetts, USA., Kohberger R; Blair & Company, LLC, Greenwich, Connecticut, USA., Higgins DE; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA., Siber GR; Genocea Biosciences, Inc., Cambridge, Massachusetts, USA., Flechtner JB; Genocea Biosciences, Inc., Cambridge, Massachusetts, USA., Geisler WM; University of Alabama at Birmingham, Birmingham, Alabama, USA.
Publikováno v:
Clinical and vaccine immunology : CVI [Clin Vaccine Immunol] 2015 Nov; Vol. 22 (11), pp. 1206-18. Date of Electronic Publication: 2015 Oct 07.
Autor:
Long D; Genocea Biosciences, Inc., Cambridge, MA USA., Skoberne M; Genocea Biosciences, Inc., Cambridge, MA USA., Gierahn TM; Genocea Biosciences, Inc., Cambridge, MA USA., Larson S; Genocea Biosciences, Inc., Cambridge, MA USA., Price JA; Genocea Biosciences, Inc., Cambridge, MA USA., Clemens V; Genocea Biosciences, Inc., Cambridge, MA USA., Baccari AE; Genocea Biosciences, Inc., Cambridge, MA USA., Cohane KP; Genocea Biosciences, Inc., Cambridge, MA USA., Garvie D; Genocea Biosciences, Inc., Cambridge, MA USA., Siber GR; Genocea Biosciences, Inc., Cambridge, MA USA., Flechtner JB; Genocea Biosciences, Inc., Cambridge, MA USA. Electronic address: jessica.flechtner@genocea.com.
Publikováno v:
Virology [Virology] 2014 Sep; Vol. 464-465, pp. 296-311. Date of Electronic Publication: 2014 Aug 09.
Autor:
de Roux A; Center for Respiratory Medicine at the Charlottenburg Castle, Charité Universitätsmedizin Berlin, Berlin, Germany. aderoux@aol.com, Schmöle-Thoma B, Siber GR, Hackell JG, Kuhnke A, Ahlers N, Baker SA, Razmpour A, Emini EA, Fernsten PD, Gruber WC, Lockhart S, Burkhardt O, Welte T, Lode HM
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2008 Apr 01; Vol. 46 (7), pp. 1015-23.
Autor:
Scott DA; Wyeth Vaccines Research, 401 N. Middletown Road, Pearl River, NY 10965, USA., Komjathy SF, Hu BT, Baker S, Supan LA, Monahan CA, Gruber W, Siber GR, Lockhart SP
Publikováno v:
Vaccine [Vaccine] 2007 Aug 14; Vol. 25 (33), pp. 6164-6. Date of Electronic Publication: 2007 Jun 26.
Autor:
Siber GR; Wyeth Vaccines Research, Pearl River, New York, USA. siberg@wyeth.com, Chang I, Baker S, Fernsten P, O'Brien KL, Santosham M, Klugman KP, Madhi SA, Paradiso P, Kohberger R
Publikováno v:
Vaccine [Vaccine] 2007 May 10; Vol. 25 (19), pp. 3816-26. Date of Electronic Publication: 2007 Feb 21.
Autor:
Santosham M; Center for American Indian Health, Department of International Health, Johns Hopkins University, 621 N. Washington Street, Baltimore, MD 21205, USA. msantosh@jhsph.edu, Reid R, Chandran A, Millar EV, Watt JP, Weatherholtz R, Donaldson C, Croll J, Moulton LH, Thompson CM, Siber GR, O'Brien KL
Publikováno v:
Vaccine [Vaccine] 2007 Mar 22; Vol. 25 (13), pp. 2366-74. Date of Electronic Publication: 2006 Sep 18.